SOS2 and cardiofaciocutaneous syndrome: SOS1 and KRAS, but not SOS2, have been implicated in human rasopathies, including mutations in SOS1 and KRAS in Noonan syndrome and KRAS mutations in cardiofaciocutaneous syndrome (31).